An update on drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors

Volume: 16, Issue: 4, Pages: 297 - 307
Published: Mar 21, 2020
Abstract
Introduction: Carbonic anhydrase inhibitors (CAIs) have been in clinical use for decades for the management of various disorders. An update on their drug-drug interactions is presented here considering these main therapeutic areas and drugs: glaucoma (acetazolamide, methazolamide, dichlorophenamide, dorzolamide, and brinzolamide); epilepsy/obesity (sulthiame, topiramate, and zonisamide); arthritis/inflammation (celecoxib and polmacoxib) and...
Paper Details
Title
An update on drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors
Published Date
Mar 21, 2020
Volume
16
Issue
4
Pages
297 - 307
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.